TTC19 Gene Mitochondrial Complex III Deficiency Nuclear Type 2 Genetic Test
Welcome to DNA Labs UAE, where we offer the TTC19 Gene Mitochondrial Complex III Deficiency Nuclear Type 2 Genetic Test. This test is designed to diagnose and provide valuable information about this rare genetic disorder.
Test Details
TTC19 gene mitochondrial complex III deficiency, nuclear type 2 is a rare genetic disorder that affects the function of mitochondria, the powerhouses of cells. This disorder is caused by mutations in the TTC19 gene, which provides instructions for making a protein involved in the assembly and stability of complex III, a critical component of the mitochondrial respiratory chain.
Mitochondrial complex III is responsible for transferring electrons during cellular respiration, which is the process that generates energy in the form of ATP. When the TTC19 gene is mutated, complex III cannot function properly, leading to a decrease in energy production and the accumulation of toxic byproducts in cells.
Test Components and Price
The TTC19 Gene Mitochondrial Complex III Deficiency Nuclear Type 2 Genetic Test is priced at 4400.0 AED. The test can be conducted using a blood sample, extracted DNA, or one drop of blood on an FTA Card.
Report Delivery
The test results will be delivered within 3 to 4 weeks from the date of sample submission.
Method
The test utilizes NGS (Next-Generation Sequencing) technology to analyze the DNA sequence of an individual’s genes.
Test Type
The TTC19 Gene Mitochondrial Complex III Deficiency Nuclear Type 2 Genetic Test falls under the category of Neurological Disorders.
Doctor and Test Department
The test is conducted by a Neurologist in our Genetics department.
Pre Test Information
Prior to undergoing the TTC19 Gene Mitochondrial Complex III Deficiency Nuclear Type 2 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the disorder.
Importance and Availability
TTC19 Gene Mitochondrial Complex III Deficiency Nuclear Type 2 is a rare disorder, and genetic testing may not be readily available in all healthcare settings. We recommend consulting with a geneticist or a healthcare professional experienced in genetic disorders to determine the appropriate testing options and accurately interpret the results.
At DNA Labs UAE, we strive to provide accurate and reliable genetic testing services. Contact us today to learn more about the TTC19 Gene Mitochondrial Complex III Deficiency Nuclear Type 2 Genetic Test and how it can benefit you.
| Test Name | TTC19 Gene Mitochondrial complex III deficiency nuclear type 2 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for TTC19 Gene Mitochondrial complex III deficiency, nuclear type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with TTC19 Gene Mitochondrial complex III deficiency, nuclear type 2 |
| Test Details |
TTC19 gene mitochondrial complex III deficiency, nuclear type 2 is a rare genetic disorder that affects the function of mitochondria, the powerhouses of cells. This disorder is caused by mutations in the TTC19 gene, which provides instructions for making a protein involved in the assembly and stability of complex III, a critical component of the mitochondrial respiratory chain. Mitochondrial complex III is responsible for transferring electrons during cellular respiration, which is the process that generates energy in the form of ATP. When the TTC19 gene is mutated, complex III cannot function properly, leading to a decrease in energy production and the accumulation of toxic byproducts in cells. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of an individual’s genes. In the case of TTC19 gene mitochondrial complex III deficiency, nuclear type 2, NGS genetic testing can be used to identify mutations in the TTC19 gene that may be causing the disorder. This testing can help confirm a diagnosis, guide treatment decisions, and provide information about the risk of passing the condition to future generations. It is important to note that TTC19 gene mitochondrial complex III deficiency, nuclear type 2 is a rare disorder, and genetic testing may not be readily available in all healthcare settings. A consultation with a geneticist or a healthcare professional experienced in genetic disorders is recommended to determine the appropriate testing options and to interpret the results accurately. |
